文献速递淋巴瘤

成人T细胞白血病淋巴瘤患者接受莫格利珠单抗治疗外周血IgG重链库的临床意义

Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumab.
PubMed 文献 · Br J Haematol · 2021-10-10

本研究基于MIMOGA多中心前瞻性研究(UMIN000008696),对81例成人T细胞白血病淋巴瘤患者的外周血单核细胞进行IgG重链库高通量测序。发现患者外周IgG B细胞库较健康个体受限,IgG库的Shannon-Weaver多样性指数与B细胞比例正相关。多因素分析显示,较高的血清可溶性白介素-2受体水平和较低的IgG库SWDI显著影响总生存。

要点

  • ATL患者外周IgG B细胞库较健康个体受限。
  • IgG库SWDI与PBMC中B细胞比例呈正相关。
  • 低IgG库SWDI和高sIL-2R水平是OS的不良预后因素。

核心结论

  • 在含莫格利珠单抗治疗的患者中,体液免疫反应具有重要性。
  • 较低的IgG重链库多样性与ATL患者较差的总生存相关。

研究设计与样本

  • MIMOGA多中心前瞻性临床研究(UMIN000008696)。
  • 101例入组患者中,81例有足够PBMC RNA用于IgG重链库高通量测序分析。
  • 多因素分析纳入44例患者。

主要发现

  • ATL患者外周IgG B细胞库较健康个体受限。
  • IgG库的Shannon-Weaver多样性指数与PBMC中B细胞比例呈显著正相关。
  • 多因素分析显示,较高的血清可溶性白介素-2受体水平和较低的IgG库SWDI显著影响OS。

临床怎么用

  • 监测IgG重链库多样性可能有助于评估接受莫格利珠单抗治疗ATL患者的预后。
  • 需进一步研究增强ATL患者体液免疫反应的策略。

局限性

  • 仅81例患者有足够样本进行库测序分析。
  • 多因素分析样本量较小(n=44)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

'Monitoring of immune responses following mogamulizumab-containing treatment in patients with adult T-cell leukaemia-lymphoma (ATL)' (MIMOGA) is a multicentre prospective clinical study (UMIN000008696). In the MIMOGA study, we found that a lower percentage of CD2- CD19+ B cells in peripheral blood mononuclear cells (PBMC) was a significant unfavourable prognostic factor for overall survival (OS). Accordingly, we then analysed the immunoglobulin G (IgG) heavy-chain repertoire in PBMC by high-throughput sequencing. Of the 101 patients enrolled in the MIMOGA study, for 81 a sufficient amount of PBMC RNA was available for repertoire sequencing analysis. Peripheral IgG B cells in patients with ATL had a restricted repertoire relative to those in healthy individuals. There was a significant positive correlation between the Shannon-Weaver diversity index (SWDI) for the IgG repertoire and proportions of B cells in the PBMC of the patients. Multivariate analysis identified two variables significantly affecting OS: a higher serum soluble interleukin-2 receptor level, and a lower SWDI for the IgG repertoire [hazard ratio, 2·124; 95% confidence interval, 1·114-4·049; n = 44]. The present study documents the importance of humoral immune responses in patients receiving mogamulizumab-containing treatment. Further investigation of strategies to enhance humoral immune responses in patients with ATL is warranted.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Nosaka K, Kusumoto S, Nakano N, et al. Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumab. Br J Haematol. 2021. PMID: 34632569. doi:10.1111/bjh.17895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。